Mari Ariyasu Selected Research

Mari Ariyasu Research Topics

6	Infections 01/2024 - 01/2017
4	COVID-19 05/2024 - 01/2022
4	Healthcare-Associated Pneumonia 01/2021 - 12/2018
3	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 12/2018
2	Sepsis (Septicemia) 01/2021 - 11/2019
2	Pneumonia (Pneumonitis) 01/2021 - 01/2021
1	Endocarditis 01/2019
1	Nausea 12/2018
1	Constipation 12/2018
1	Pyelonephritis 12/2018
1	Vomiting 12/2018
1	Abdominal Pain (Pain, Abdominal) 12/2018
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2018

6	CefiderocolIBA 01/2021 - 12/2018
5	Carbapenems (Carbapenem Antibiotics)IBA 01/2021 - 01/2017
3	VaccinesIBA 05/2024 - 01/2022
3	S-268019-b COVID-19 vaccineIBA 05/2024 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
1	Protein Subunits (Protein Subunit)IBA 05/2024
1	ChAdOx1 nCoV-19IBA 01/2024
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2024
1	BNT162 VaccineIBA 01/2022
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2021
1	Polymyxins (Polymyxin)IBA 01/2021
1	Meropenem (Merrem)FDA LinkGeneric 01/2021
1	beta-Lactamases (beta-Lactamase)IBA 01/2019
1	Colistin (Coly-Mycin)FDA Link 01/2019
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 12/2018

2	Intravenous Infusions 01/2021 - 12/2018
2	Therapeutics 01/2021 - 11/2019
1	Intramuscular Injections 01/2024
1	Mechanical Ventilators (Ventilator) 01/2021
1	Length of Stay 01/2017